We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Buys

Rank Stock Value
1
CPAY icon
Corpay
CPAY
+$58.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$45.3M
3
BKR icon
Baker Hughes
BKR
+$45.2M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$43.6M
5
RCL icon
Royal Caribbean
RCL
+$40.1M

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNC icon
201
PNC Financial Services
PNC
$99.1B
$26.6M 0.18%
166,367
-3,252
-2% -$488K
COLD icon
202
Americold
COLD
$4.21B
$26.5M 0.18%
756,250
-529,750
-41% -$19.5M
GH icon
203
Guardant Health
GH
$19.1B
$26.2M 0.18%
335,487
+180,180
+116% +$13M
GNRC icon
204
Generac Holdings
GNRC
$11.5B
$26.1M 0.17%
259,100
-95,450
-27% -$8.89M
FCN icon
205
FTI Consulting
FCN
$5.14B
$25.8M 0.17%
233,550
-29,925
-11% -$3.27M
MRTX
206
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$25.7M 0.17%
+199,814
New +$19.3M
BRO icon
207
Brown & Brown
BRO
$25.1B
$25.7M 0.17%
649,975
-676,250
-51% -$25.4M
ATO icon
208
Atmos Energy
ATO
$29.7B
$25.6M 0.17%
229,099
-188,550
-45% -$20.7M
MCD icon
209
McDonald's
MCD
$193B
$25.5M 0.17%
128,935
-2,521
-2% -$500K
EVH icon
210
Evolent Health
EVH
$371M
$25.3M 0.17%
2,801,065
– –
ACGL icon
211
Arch Capital
ACGL
$35.7B
$25.2M 0.17%
588,000
-17,750
-3% -$736K
HST icon
212
Host Hotels & Resorts
HST
$17.5B
$25.2M 0.17%
1,356,509
-44,125
-3% -$763K
MDT icon
213
Medtronic
MDT
$112B
$25M 0.17%
220,640
-4,314
-2% -$473K
INSM icon
214
Insmed
INSM
$22.4B
$25M 0.17%
1,046,301
– –
ADP icon
215
Automatic Data Processing
ADP
$109B
$25M 0.17%
146,394
-2,862
-2% -$474K
LRCX icon
216
Lam Research
LRCX
$316B
$24.9M 0.17%
+850,750
New +$22.6M
UNP icon
217
Union Pacific
UNP
$174B
$24.8M 0.17%
137,125
-42,438
-24% -$7.27M
DRNA
218
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$24.7M 0.16%
1,120,359
– –
EVBG
219
DELISTED
Everbridge, Inc. Common Stock
EVBG
$24.6M 0.16%
314,669
+10,000
+3% +$772K
GBT
220
DELISTED
Global Blood Therapeutics, Inc.
GBT
$24.4M 0.16%
307,452
– –
CMCSA icon
221
Comcast
CMCSA
$87.3B
$24.4M 0.16%
543,202
-20,120
-4% -$896K
CCI icon
222
Crown Castle
CCI
$34.6B
$24.4M 0.16%
171,322
-3,350
-2% -$457K
TTE icon
223
TotalEnergies
TTE
$193B
$23.8M 0.16%
430,466
-8,415
-2% -$445K
EEFT icon
224
Euronet Worldwide
EEFT
$3.19B
$23.6M 0.16%
149,900
+132,400
+757% +$20M
BMRN icon
225
BioMarin Pharmaceuticals
BMRN
$11.9B
$23.3M 0.16%
276,075
+196,650
+248% +$14.9M
7 8
9
10 11

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.